News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Pharm Country
Dendreon Corporation President and CEO to Ring The NASDAQ Stock Market Opening Bell
May 27, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ADVISORY, May 27, 2010 (GLOBE NEWSWIRE) -- What: Mitchell Gold, President and CEO of Dendreon Corporation (DNDN), will visit NASDAQ MarketSite in Times Square and preside over the NASDAQ Opening Bell.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Cancer
AACR 2025 Tracker: Merck, GSK, Roche and More Present Key Data
April 30, 2025
·
8 min read
·
BioSpace Editorial Staff
Duchenne muscular dystrophy
Safety Questions Loom in Duchenne as Dyne, Wave and Others Plan FDA Filings
March 27, 2025
·
8 min read
·
Heather McKenzie
Spinal muscular atrophy
Novartis’ Intrathecal Zolgensma Effective in Older Children
March 19, 2025
·
6 min read
·
Heather McKenzie
Editorial
Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity
February 28, 2025
·
4 min read
·
Heather McKenzie
